Ep.76 - Two Orthopedic Surgeons Discuss Cellular Medicine: Dr. Seeds and Dr. Rahman in Conversation

About this video

Orthopedic surgeons Seeds and Dr. Rahman discuss why both moved toward cellular and regenerative medicine. Rahman describes a large gray zone in training at Lenox Hill and Kerlan-Jobe: patients who failed physical therapy and injections but were not ready for joint replacement, and athletes desperate to avoid season-ending surgery. They review orthobiologics such as PRP and bone marrow concentrate with their limitations, argue surgery is irreversible and should follow metabolic optimization and careful phenotyping, and stress evidence collection. Rahman warns patients against self-sourcing peptides, which the speakers frame as precise medicines requiring medical supervision and monitoring, not experimentation.

Key takeaways

• The hardest orthopedic patients are often in a gray zone between failed conservative care and surgery
• Surgery cannot be undone, so the speakers argue for exhausting reversible, biology-focused options first
• PRP and bone marrow approaches are presented as useful but variable and still procedural
• Credibility in this field requires prospective data and validated outcome measures, not anecdotes alone
• Patient enthusiasm for peptides must be met with supervision and safety guidance, the speakers argue

Episode details: published September 8, 2026 · 241 views · 36:30 long. Summary written by Self Growth Videos from the episode itself. The peptide and cellular-medicine concepts described are Dr. William Seeds’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: the SSRP Institute sells clinician certification in peptide therapy.

← Previous: Can Peptides Transform Orthopedic Medicine? · Next: Ep.77 - Enhancing Orthopedic Outcomes and Improving Healing in Patients with Dr. Rahman →

All Dr. William Seeds videos · Dr. William Seeds profile · SSRP Institute (official site)